Nonamyloidogenic processing of amyloid beta precursor protein is associated with retinal function improvement in

Sandrine Joly1, Simon Lamoureux1, Vincent Pernet1

  • 1CUO-Recherche, Centre de recherche du CHU de Québec and Département d'ophtalmologie, Faculté de médecine, Université Laval, Québec, Québec, Canada.

Neurobiology of Aging
|March 7, 2017
PubMed

Insights

Alzheimer's disease (AD) models show preserved cone vision in aging mice. Retinal amyloid processing may protect against vision loss, suggesting a unique protective mechanism in the aging eye.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Gerontology

Background:

  • Normal aging and Alzheimer's disease (AD) are associated with vision decline.
  • The role of amyloid beta (Aβ) in AD pathogenesis is known, but its effect on the aging retina is unclear.

Purpose of the Study:

  • To investigate the impact of AD-related genetic mutations on retinal cell function and survival.
  • To determine if amyloid processing in the retina differs from the brain and influences vision during aging.

Main Methods:

  • Utilized APPswe/PS1ΔE9 transgenic (TG) mice, a standard AD model.
  • Assessed retinal function using electroretinogram (ERG) recordings.
  • Examined retinal cell survival via immunofluorescent stainings.

Main Results:

  • Photopic ERG revealed preserved cone-mediated retinal responses in aging TG mice compared to wild-type (WT) controls.
  • Amyloid beta (Aβ) plaques and mutated APP/PS1 were not detected in the retinae of 13-month-old male TG mice.
  • A lower CTFβ/CTFα ratio in retinal samples suggested a dominant nonamyloidogenic pathway limiting Aβ formation.

Conclusions:

  • Retinal-specific amyloid processing may offer protection against AD-related vision impairment.
  • Cone-dependent vision appears selectively preserved in aging mice with AD genetic models.
  • The nonamyloidogenic pathway might play an endogenous protective role in the aging retina.

Related Concept Videos